CIMICIFUGA PLEX
CIMICIFUGA PLEX
Discontinued
DIN Number
02235035
Drug Class
Human
Market Date
Apr 6, 1998
Company
HC
seroyal international inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02235035
AIG Number1232430001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
,
Drops
,
Granules
,
Syrup
,
Pellet
,
Tablet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (12)
CAULOPHYLLUM THALICTROIDESActive
Strength: 6 X
Monograph: CAULOPHYLLUM THALICTROIDES
CIMICIFUGA RACEMOSAActive
Strength: 6 X
Monograph: CIMICIFUGA RACEMOSA
COPPERActive
Strength: 6 X
Monograph: COPPER
COTTON PLANTActive
Strength: 6 X
Monograph: COTTON PLANT
ESTRONEActive
Strength: 12 X
Monograph: ESTRONE
HISTAMINE DIHYDROCHLORIDEActive
Strength: 12 X
Monograph: HISTAMINE DIHYDROCHLORIDE
HYPOTHALAMUSActive
Strength: 10 X
Monograph: HYPOTHALAMUS
MAGNESIUM PHOSPHATE DIBASICActive
Strength: 6 X
Monograph: MAGNESIUM PHOSPHATE DIBASIC
PITUITARY WHOLEActive
Strength: 10 X
Monograph: PITUITARY WHOLE
PLATINUMActive
Strength: 8 X
Monograph: PLATINUM
SEPIA OFFICINALIS LActive
Strength: 6 X
Monograph: SEPIA OFFICINALIS L
THYROIDActive
Strength: 10 X
Monograph: THYROID